Swedish Animal Drug Maker Launches U.S. Subsidiary

Premune is making a serious push into the U.S. companion animal market.


Published:

Follow Veterinary Practice News on Twitter at @vetpetnews.

Premune, a Swedish veterinary drug company, is making a serious push into the U.S. companion animal market by establishing a U.S. subsidiary, Premune Inc., in New York.

Viktor Karlsson, CEO and cofounder of Premune AB, called the move "a significant milestone for our company as we continue building our global presence."

"Pet-related spending in the U.S. has increased for each of the last 20 years, making it one of the few industries immune to macroeconomic weakness," Karlsson said.

 Premune logo
Premune develops treatments for allergies, inflammatory bowel disease and other immune disorders.

The company's global partnering, licensing and business development efforts will spring from the New York headquarters. Premune's core research and development team will remain in Sweden.

Premune Inc. is busy building an initial staff of about 10. A series of announcements is expected in the coming weeks, a spokesman said, as executive positions such as chief marketing officer and chief financial officer are filled.

The New York office is expected to open in June.

Among the products under development is one code-named PRE01, which, if approved, would be the world?s first preventive treatment for canine allergies, according to the company.

Premune has shown that delayed exposure to gut bacteria is a major risk factor for allergies in humans. Applying the finding to companion animal health is the basis for several products in the company's pipeline.

Other Premune products in the works are treatments for ear infections and intestinal conditions in cats and dogs.

Previous: Parvo Puppies and Sharing What You Know
Want more Veterinary Practice News? Go here.

<HOME>

Archive »Read More

Too Many Veterinarians, or a Bubble Market?

How can a scientifically trained profession keep ignoring the facts of too many graduates chasing too few jobs with an ever increasing debt burden?

Former Head of ASPCA Takes Over at PIJAC

The pet industry reacts over the controversial decision to hire former ASPCA executive Edwin J. Sayres as president and CEO of the Pet Industry Joint Advisory Council.

K-State Offers New Course on Regulation of Animal Drugs, Vaccines

The course begins this fall and is available through distance learning or on the K-State Olathe campus.

Add your comment:

Events


Show More...